Department of Addictive Behavior and Addiction Medicine, the Central Institute of Mental Health, Mannheim, Germany.
J Addict Med. 2011 Sep;5(3):203-13. doi: 10.1097/ADM.0b013e31820b3e3d.
Despite a large number of empirical reports of impaired decision making in substance use disorders, the underlying factors contributing to such deficits remain to be elucidated. This study examined the potential influences of personality traits, affective symptoms, and pharmacological variables on decision making, as measured by the Iowa Gambling Task (IGT) in a sample of opioid-dependent patients.
A total of 46 opioid-dependent patients taking part in an opiate maintenance outpatient program and 46 healthy control subjects performed the IGT. Personality traits and affective symptoms were examined by using Zuckerman Sensation-Seeking Scale, the State-Trait Anxiety Inventory and Beck Depression Inventory. In addition, Cloninger Temperament and Character Inventory was administered in the patient group. Information on current and life-time substance use was acquired with a standardized interview.
Opioid-dependent patients performed significantly worse on the IGT than controls. This difference disappeared after statistically controlling for trait anxiety, state anxiety, disinhibition, depressive symptoms, and lifetime alcohol consumption. Trait and state anxiety and self-directedness were significantly associated with the IGT final score. Hierarchical regression analyses suggested that self-directedness differentially moderated the relationships between the anxiety variables and IGT performance.
The decision-making impairments observed in opioid-dependent patients are influenced by current levels of anxiety and the personality markers trait anxiety and self-directedness. Differences in decision making between opioid-dependent and healthy individuals may also be due to differences in other personality facets, affective symptoms, and alcohol consumption. Amount of opioid and other substance intake did not show any effects. These results indicate that psychological characteristics may have a higher impact on decision-making performance than drug-induced pharmacological effects.
尽管有大量关于物质使用障碍患者决策能力受损的经验报告,但导致这些缺陷的潜在因素仍有待阐明。本研究通过对阿片类依赖患者进行的 Iowa 赌博任务(IGT)评估,考察了人格特质、情感症状和药理学变量对决策的潜在影响。
共有 46 名接受阿片类维持门诊治疗的阿片类依赖患者和 46 名健康对照者参与了 IGT 测试。采用 Zuckerman 感觉寻求量表、状态特质焦虑量表和贝克抑郁量表评估人格特质和情感症状。此外,在患者组中还进行了 Cloninger 气质与性格问卷评估。通过标准化访谈获取当前和终身药物使用信息。
阿片类依赖患者在 IGT 上的表现明显差于对照组。在统计控制了特质焦虑、状态焦虑、冲动性、抑郁症状和终身酒精使用后,这种差异消失了。特质焦虑和状态焦虑以及自我导向与 IGT 最终得分显著相关。分层回归分析表明,自我导向性差异调节了焦虑变量与 IGT 表现之间的关系。
阿片类依赖患者观察到的决策障碍受到当前焦虑水平以及人格特征特质焦虑和自我导向性的影响。阿片类依赖者和健康个体之间决策差异也可能归因于其他人格特质、情感症状和酒精摄入的差异。阿片类药物和其他物质的摄入量没有显示出任何影响。这些结果表明,心理特征对决策表现的影响可能高于药物引起的药理学效应。